GENOMENEXT

genomenext-logo

GenomeNext delivers an automated genomic analysis solution that provides researchers and clinicians with a real-time, secure and regulatory compliant environment to analyze genomic data. The GenomeNext analysis pipeline is the first comprehensive solution that can deliver accurate, reproducible and determinate genomic analysis results, from FASTQ to VCF to annotation in under 3 hours for whole genomes, under 1 hour per exome and 30 minutes per panel. GenomeNext delivers an automated genomic a... nalysis solution that provides researchers and clinicians with a real-time, secure and regulatory compliant environment to analyze genomic data. The GenomeNext analysis pipeline is the first comprehensive solution that can deliver accurate, reproducible and determinate genomic analysis results, from FASTQ to VCF to annotation in under 2 hours for whole genomes, under 1 hour per exome and 30 minutes per panel. Our proprietary algorithm powers a streamlined analysis platform delivering deterministic analyses to ensure your results are accurate and reproducible the first time and every time. Our analysis pipeline follows the commonly accepted best practices for both single sample and multisample variant discovery by performing alignment, deduplication, local realignment around indels, base quality score recalibration, variant calling and genotyping. Each step of the GenomeNext analysis pipeline has been carefully architected to rapidly align raw sequence reads to a reference genome, refine this alignment in areas where it is known that aligners can have difficulties, clean up lab prep and sequencer-related artifacts, and perform discovery of variants and genotypes with a high degree of confidence. GenomeNext automated analysis platform features: -Run exomes, targeted panels, and whole genomes -Run multiple samples in one analysis request -Analysis results in under 2 hours -100% Reproducible and Deterministic Results -Immediate download of VCF and Annotation files -Visualization of analyzed data -Cost-effective solution for clinical and research needs -Regulatory compliant platform -Enables population scale genomics -Secure storage of large genomic data -Secure platform that can be accessed from anywhere in the world -Reduce computational bottleneck -Collaboration platform for teams -Unlimited user accounts with access control features.

#SimilarOrganizations #People #Financial #Website #More

GENOMENEXT

Social Links:

Industry:
Biotechnology Genetics

Founded:
2014-03-15

Address:
Columbus, Ohio, United States

Country:
United States

Website Url:
http://www.genomenext.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
1.2 M USD

Technology used in webpage:
Apache YouTube ASP.NET IIS DigiCert SSL ASP.NET 4.0 Amazon SSL IIS 8 Digital Ocean ASP.NET MVC


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

peter-white_image

Peter White
Peter White Co-Founder and Chief Scientific Advisor @ GenomeNext
Co-Founder and Chief Scientific Advisor
2014-03-01

Founder


christopher-s-drescher_image

Christopher S. Drescher

james-hirmas_image

James Hirmas

peter-white_image

Peter White

Investors List

hydra-capital_image

Hydra Capital

Hydra Capital investment in Seed Round - GenomeNext

Official Site Inspections

http://www.genomenext.com

  • Host name: 164.90.244.158
  • IP address: 164.90.244.158
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "GenomeNext" on Search Engine